http://www.activewallst.com/register/.

At the close of the Canadian markets on Thursday, April 20, 2017, the Toronto Exchange Composite index ended the trading session at 15,625.56, 0.47% higher from its previous closing price.

The Healthcare Index was in the red, closing the day at 63.73, down 0.87%.

Active Wall St. has initiated research reports on the following equities: ProMetic Life Sciences Inc. (TSX: PLI), Concordia International Corporation (TSX: CXR), Theratechnologies Inc. (TSX: TH), and Aurinia Pharmaceuticals Inc. (TSX: AUP). Register with us now for your free membership and research reports at: http://www.activewallst.com/register/.

ProMetic Life Sciences Inc. (TSX: PLI)

Laval, Canada headquartered ProMetic Life Sciences Inc.'s stock advanced 1.44%, to finish Thursday's session at $2.12 with a total volume of 600,412 shares traded. Shares of the Company, which develops bio separations, plasma-derived therapeutics, and small-molecule drugs, are trading below its 50-day and 200-day moving averages. ProMetic Life Sciences' 200-day moving average of $2.37 is above its 50-day moving average of $2.26. See our research report on PLI.TO at: http://www.activewallst.com/register/.

Concordia International Corp. (TSX: CXR)

On Thursday, shares in Oakville, Canada headquartered Concordia International Corp. recorded a trading volume of 108,024 shares. The stock ended the day 0.55% higher at $1.84. Shares of the Company, which through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products, are trading below its 50-day and 200-day moving averages. The stock's 200-day moving average of $3.32 is above its 50-day moving average of $2.31. The complimentary research report on CXR.TO at: http://www.activewallst.com/register/.

Theratechnologies Inc. (TSX: TH)

On Thursday, shares in Montreal, Canada headquartered Theratechnologies Inc. ended the session 1.85% higher at $6.06 with a total volume of 284,631 shares traded. Theratechnologies' shares have gained 12.64% in the last one month and 94.23% in the previous three months. Furthermore, the stock has rallied 209.18% in the past one year. Shares of the company, which addresses unmet medical needs to promote healthy living and an enhanced life among HIV patients, are trading above its 50-day and 200-day moving averages. Furthermore, the stock's 50-day moving average of $5.61 is greater than its 200-day moving average of $3.81. Register for free and access the latest research report on TH.TO at: http://www.activewallst.com/register/.

Aurinia Pharmaceuticals Inc. (TSX: AUP)

Victoria, Canada headquartered Aurinia Pharmaceuticals Inc.'s stock closed the day 1.07% higher at $9.42. The stock recorded a trading volume of 130,479 shares. Aurinia Pharma's shares have rallied 181.19% in the last three months and 243.80% in the past one year. Shares of the company, which engages in the development of a therapeutic drug to treat autoimmune diseases in Canada and internationally, are trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $9.61 is greater than its 200-day moving average of $5.54. Get free access to your research report on AUP.TO at: http://www.activewallst.com/register/.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 460244

"/> Research Reports Initiated on Healthcare Stocks ProMetic Life Sciences, Concordia International, Theratechnologies, and Aurinia Pharmaceuticals « MarketersMedia – Press Release Distribution Services – News Release Distribution Services

Research Reports Initiated on Healthcare Stocks ProMetic Life Sciences, Concordia International, Theratechnologies, and Aurinia Pharmaceuticals

LONDON, UK / ACCESSWIRE / April 21, 2017 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Biotechnology industry. Companies recently under review include ProMetic Life Sciences, Concordia International, Theratechnologies, and Aurinia Pharmaceuticals. Get all of our free research reports by signing up at: http://www.activewallst.com/register/.

At the close of the Canadian markets on Thursday, April 20, 2017, the Toronto Exchange Composite index ended the trading session at 15,625.56, 0.47% higher from its previous closing price.

The Healthcare Index was in the red, closing the day at 63.73, down 0.87%.

Active Wall St. has initiated research reports on the following equities: ProMetic Life Sciences Inc. (TSX: PLI), Concordia International Corporation (TSX: CXR), Theratechnologies Inc. (TSX: TH), and Aurinia Pharmaceuticals Inc. (TSX: AUP). Register with us now for your free membership and research reports at: http://www.activewallst.com/register/.

ProMetic Life Sciences Inc. (TSX: PLI)

Laval, Canada headquartered ProMetic Life Sciences Inc.'s stock advanced 1.44%, to finish Thursday's session at $2.12 with a total volume of 600,412 shares traded. Shares of the Company, which develops bio separations, plasma-derived therapeutics, and small-molecule drugs, are trading below its 50-day and 200-day moving averages. ProMetic Life Sciences' 200-day moving average of $2.37 is above its 50-day moving average of $2.26. See our research report on PLI.TO at: http://www.activewallst.com/register/.

Concordia International Corp. (TSX: CXR)

On Thursday, shares in Oakville, Canada headquartered Concordia International Corp. recorded a trading volume of 108,024 shares. The stock ended the day 0.55% higher at $1.84. Shares of the Company, which through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products, are trading below its 50-day and 200-day moving averages. The stock's 200-day moving average of $3.32 is above its 50-day moving average of $2.31. The complimentary research report on CXR.TO at: http://www.activewallst.com/register/.

Theratechnologies Inc. (TSX: TH)

On Thursday, shares in Montreal, Canada headquartered Theratechnologies Inc. ended the session 1.85% higher at $6.06 with a total volume of 284,631 shares traded. Theratechnologies' shares have gained 12.64% in the last one month and 94.23% in the previous three months. Furthermore, the stock has rallied 209.18% in the past one year. Shares of the company, which addresses unmet medical needs to promote healthy living and an enhanced life among HIV patients, are trading above its 50-day and 200-day moving averages. Furthermore, the stock's 50-day moving average of $5.61 is greater than its 200-day moving average of $3.81. Register for free and access the latest research report on TH.TO at: http://www.activewallst.com/register/.

Aurinia Pharmaceuticals Inc. (TSX: AUP)

Victoria, Canada headquartered Aurinia Pharmaceuticals Inc.'s stock closed the day 1.07% higher at $9.42. The stock recorded a trading volume of 130,479 shares. Aurinia Pharma's shares have rallied 181.19% in the last three months and 243.80% in the past one year. Shares of the company, which engages in the development of a therapeutic drug to treat autoimmune diseases in Canada and internationally, are trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $9.61 is greater than its 200-day moving average of $5.54. Get free access to your research report on AUP.TO at: http://www.activewallst.com/register/.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 460244

LONDON, UK / ACCESSWIRE / April 21, 2017 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Biotechnology industry. Companies recently under review include ProMetic Life Sciences, Concordia International, Theratechnologies, and Aurinia Pharmaceuticals. Get all of our free research reports by signing up at: http://www.activewallst.com/register/.

At the close of the Canadian markets on Thursday, April 20, 2017, the Toronto Exchange Composite index ended the trading session at 15,625.56, 0.47% higher from its previous closing price.

The Healthcare Index was in the red, closing the day at 63.73, down 0.87%.

Active Wall St. has initiated research reports on the following equities: ProMetic Life Sciences Inc. (TSX: PLI), Concordia International Corporation (TSX: CXR), Theratechnologies Inc. (TSX: TH), and Aurinia Pharmaceuticals Inc. (TSX: AUP). Register with us now for your free membership and research reports at: http://www.activewallst.com/register/.

ProMetic Life Sciences Inc. (TSX: PLI)

Laval, Canada headquartered ProMetic Life Sciences Inc.'s stock advanced 1.44%, to finish Thursday's session at $2.12 with a total volume of 600,412 shares traded. Shares of the Company, which develops bio separations, plasma-derived therapeutics, and small-molecule drugs, are trading below its 50-day and 200-day moving averages. ProMetic Life Sciences' 200-day moving average of $2.37 is above its 50-day moving average of $2.26. See our research report on PLI.TO at: http://www.activewallst.com/register/.

Concordia International Corp. (TSX: CXR)

On Thursday, shares in Oakville, Canada headquartered Concordia International Corp. recorded a trading volume of 108,024 shares. The stock ended the day 0.55% higher at $1.84. Shares of the Company, which through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products, are trading below its 50-day and 200-day moving averages. The stock's 200-day moving average of $3.32 is above its 50-day moving average of $2.31. The complimentary research report on CXR.TO at: http://www.activewallst.com/register/.

Theratechnologies Inc. (TSX: TH)

On Thursday, shares in Montreal, Canada headquartered Theratechnologies Inc. ended the session 1.85% higher at $6.06 with a total volume of 284,631 shares traded. Theratechnologies' shares have gained 12.64% in the last one month and 94.23% in the previous three months. Furthermore, the stock has rallied 209.18% in the past one year. Shares of the company, which addresses unmet medical needs to promote healthy living and an enhanced life among HIV patients, are trading above its 50-day and 200-day moving averages. Furthermore, the stock's 50-day moving average of $5.61 is greater than its 200-day moving average of $3.81. Register for free and access the latest research report on TH.TO at: http://www.activewallst.com/register/.

Aurinia Pharmaceuticals Inc. (TSX: AUP)

Victoria, Canada headquartered Aurinia Pharmaceuticals Inc.'s stock closed the day 1.07% higher at $9.42. The stock recorded a trading volume of 130,479 shares. Aurinia Pharma's shares have rallied 181.19% in the last three months and 243.80% in the past one year. Shares of the company, which engages in the development of a therapeutic drug to treat autoimmune diseases in Canada and internationally, are trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $9.61 is greater than its 200-day moving average of $5.54. Get free access to your research report on AUP.TO at: http://www.activewallst.com/register/.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 460244

Source URL: https://marketersmedia.com/research-reports-initiated-on-healthcare-stocks-prometic-life-sciences-concordia-international-theratechnologies-and-aurinia-pharmaceuticals/189145

Source: AccessWire

Release ID: 189145


Latest News